Niemann-Pick Diseases Clinical Trial
Official title:
Understanding Health Insurance Literacy and Challenges in Accessing Health Services in Niemann-Pick Disease Through the Eyes of Patients and Families
Verified date | October 2020 |
Source | National Niemann-Pick Disease Foundation |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This study is a US based qualitative PRO research study to document the health insurance
literacy as well as the patient experience in Niemann-Pick as it relates to accessing desired
care, services and medications for patients.
The outcome of this research will be used to inform various other workstreams as NNPDF works
to assist families.
The core research objectives are to understand the following from Niemann-Pick patients and
their families in the US
Status | Completed |
Enrollment | 76 |
Est. completion date | September 21, 2020 |
Est. primary completion date | September 21, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Participant must be a person with Niemann-Pick disease who is 18 years or older or The parent/legal guardian of a person with Niemann-Pick disease. Please note: Parents whose child has passed on are able to participate in the RSVP. Parents whose child has passed on in the last two years are also able to participate in the interview. Please note that only one family member will be eligible to complete the RSVP and interview for one family. - Confirmed diagnosis of Niemann-Pick disease, confirmed by membership in the NNPDF or by provision of a proof of disease form - Able to read, write and communicate in English - Able to grant informed consent - Willing to complete a survey and RSVP, and to participate in a 30-minute telephone interview - Ability to view or receive a document from the interviewer before or during the interview (web browser, ability to receive a text, fax or document by mail) Exclusion Criteria: - Inability to meet any of the above 6 criteria |
Country | Name | City | State |
---|---|---|---|
United States | Icahn School of Medicine at Mount Sinai | New York | New York |
Lead Sponsor | Collaborator |
---|---|
National Niemann-Pick Disease Foundation | Engage Health, Inc., Icahn School of Medicine at Mount Sinai |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Health Insurance Literacy | Health insurance literacy will be measured by a score on a brief quiz regarding health insurance key terms as well as self-ratings regarding various aspects of the participants' ability to navigate and understand insurance | July 2020- September | |
Primary | Health Insurance Coverage | Health insurance coverage will be measured by the different multiple choice and open-ended questions based on the services available under the participants' insurance plan as well as their reported difficulty with navigating their plan and obtaining what they need for Niemann-Pick | July 2020- September |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05641103 -
PREDIGA 2: Spanish Acronym of "Educational and Diagnostic Project for Gaucher and ASMD"
|
||
Completed |
NCT03883750 -
Induced Pluripotent Stem Cells for Niemann Pick Disease
|
||
Recruiting |
NCT03333200 -
Longitudinal Study of Neurodegenerative Disorders
|
||
Recruiting |
NCT06192576 -
A Real-world Long-term Safety and Immunogenicity Study of Olipudase Alfa Therapy in Pediatric Patients Less Than 2 Years of Age With Acid Sphingomyelinase Deficiency (ASMD)
|